Skip to main content
Article
Response to 'Pervasive Sequence Patents Cover the Entire Human Genome'
Genome Medicine
  • Shine Tu
  • Yaniv Heled, Georgia State University College of Law
Document Type
Article
Publication Date
1-1-2014
Abstract
In a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims – which define the legal scope of a patent – in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed.
Comments

External Links
SSRN

DOI
10.1186/gm531
Citation Information
Shine Tu, et al., Response to 'Pervasive Sequence Patents Cover the Entire Human Genome', 6 Genome Med. 14 (2014).